Evol Nutrition Associates, Inc.
FEI 3008814202 · 1775 W Oak Pkwy Ste 850, Marietta, Georgia, 30062-2202, United States
2 warning letters on record
Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports
Get a dated evidence report for this supplierFree · for your supplier file · sample
Import alerts
0
Import refusals (5 years)
0
Warning letters
2
Last FDA action
2024-07-09
2 years ago
FDA record
- 2024-07-09InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2024-07-09InspectionFDA inspection · Classification: No Action Indicated (NAI)Project area: Foodborne Biological HazardsFDA source
- 2022-03-07InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2022-03-07InspectionFDA inspection · Classification: No Action Indicated (NAI)Project area: Foodborne Biological HazardsFDA source
- 2020-01-30InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2019-04-10Warning letterFDA Warning Letter (CFSAN)FDA source
- 2018-12-13InspectionFDA inspection · Classification: Official Action Indicated (OAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2016-08-12InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Foodborne Biological HazardsFDA source
- 2016-08-12InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2013-02-04InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2012-07-10Warning letterFDA Warning Letter (CFSAN)FDA source
- 2011-07-29InspectionFDA inspection · Classification: Official Action Indicated (OAI)Project area: Food Composition, Standards, Labeling and EconFDA source